US Drug Approval A040888

Methylprednisolone Sodium Succinate  Jul 18, 2011

5 approved drug products.
Methylprednisolone Sodium Succinate
  • Ingredients: Methylprednisolone Sodium Succinate;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 1gm base/vial;
  • Approval date: July 18, 2011;
  • Marketing status: prescription.
Methylprednisolone Sodium Succinate
  • Ingredients: Methylprednisolone Sodium Succinate;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 2gm base/vial;
  • Approval date: July 18, 2011;
  • Marketing status: prescription.
Methylprednisolone Sodium Succinate
  • Ingredients: Methylprednisolone Sodium Succinate;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 40mg base/vial;
  • Approval date: July 18, 2011;
  • Marketing status: prescription.
Methylprednisolone Sodium Succinate
  • Ingredients: Methylprednisolone Sodium Succinate;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 125mg base/vial;
  • Approval date: July 18, 2011;
  • Marketing status: prescription.
Methylprednisolone Sodium Succinate
  • Ingredients: Methylprednisolone Sodium Succinate;
  • Dosage form: injectable;
  • Route of administration: injection;
  • Strength: eq 500mg base/vial;
  • Approval date: July 18, 2011;
  • Marketing status: prescription.

Parties

Applicants
Countries
US

JSON preview

Similar records

Title

Source:  FDA Last updated:  Jul 8, 2019

From the Orange Book, a publication of the U.S. Food and Drug Administration. This record may not reflect the most current and accurate biomedical/scientific data available from the FDA.